364 related articles for article (PubMed ID: 3098846)
1. In vivo and in vitro activation of alveolar macrophages by recombinant interferon-gamma.
Black CM; Catterall JR; Remington JS
J Immunol; 1987 Jan; 138(2):491-5. PubMed ID: 3098846
[TBL] [Abstract][Full Text] [Related]
2. Inability of recombinant interferon-gamma to activate the antibacterial activity of mouse peritoneal macrophages against Listeria monocytogenes and Salmonella typhimurium.
van Dissel JT; Stikkelbroeck JJ; Michel BC; van den Barselaar MT; Leijh PC; van Furth R
J Immunol; 1987 Sep; 139(5):1673-8. PubMed ID: 2957433
[TBL] [Abstract][Full Text] [Related]
3. Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma.
Murray HW; Spitalny GL; Nathan CF
J Immunol; 1985 Mar; 134(3):1619-22. PubMed ID: 3918107
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide-independent killing of Francisella tularensis by IFN-gamma-stimulated murine alveolar macrophages.
Polsinelli T; Meltzer MS; Fortier AH
J Immunol; 1994 Aug; 153(3):1238-45. PubMed ID: 8027551
[TBL] [Abstract][Full Text] [Related]
5. Intravenous injection of interferon-gamma inhibits the proliferation of Listeria monocytogenes in the liver but not in the spleen and peritoneal cavity.
Langermans JA; van der Hulst ME; Nibbering PH; van der Meide PH; van Furth R
Immunology; 1992 Nov; 77(3):354-61. PubMed ID: 1478682
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo activation of human mononuclear phagocytes by interferon-gamma. Studies with normal and AIDS monocytes.
Murray HW; Scavuzzo D; Jacobs JL; Kaplan MH; Libby DM; Schindler J; Roberts RB
J Immunol; 1987 Apr; 138(8):2457-62. PubMed ID: 3104467
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.
Bermudez LE; Young LS
J Immunol; 1988 May; 140(9):3006-13. PubMed ID: 2834450
[TBL] [Abstract][Full Text] [Related]
8. Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and interferon-gamma.
Murray HW; Gellene RA; Libby DM; Rothermel CD; Rubin BY
J Immunol; 1985 Oct; 135(4):2374-7. PubMed ID: 3928746
[TBL] [Abstract][Full Text] [Related]
9. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.
Reed SG
J Immunol; 1988 Jun; 140(12):4342-7. PubMed ID: 3131431
[TBL] [Abstract][Full Text] [Related]
10. IFN-gamma-activated human alveolar macrophages inhibit the intracellular multiplication of Legionella pneumophila.
Nash TW; Libby DM; Horwitz MA
J Immunol; 1988 Jun; 140(11):3978-81. PubMed ID: 3131422
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha triggers antitoxoplasmal activity of IFN-gamma primed macrophages.
Sibley LD; Adams LB; Fukutomi Y; Krahenbuhl JL
J Immunol; 1991 Oct; 147(7):2340-5. PubMed ID: 1918966
[TBL] [Abstract][Full Text] [Related]
12. Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro.
Chen GH; Curtis JL; Mody CH; Christensen PJ; Armstrong LR; Toews GB
J Immunol; 1994 Jan; 152(2):724-34. PubMed ID: 8283047
[TBL] [Abstract][Full Text] [Related]
13. Modulation of macrophage suppressive activity and prostaglandin release by lymphokines and interferon: comparison of alveolar, pleural and peritoneal macrophages.
Sestini P; Tagliabue A; Boraschi D
Clin Exp Immunol; 1984 Dec; 58(3):573-80. PubMed ID: 6509795
[TBL] [Abstract][Full Text] [Related]
14. Macrophage-dependent candidacidal mechanisms in the murine system. Comparison of murine Kupffer cell and peritoneal macrophage candidacidal mechanisms.
Redmond HP; Shou J; Gallagher HJ; Kelly CJ; Daly JM
J Immunol; 1993 Apr; 150(8 Pt 1):3427-33. PubMed ID: 8385685
[TBL] [Abstract][Full Text] [Related]
15. [Effects of interferon-gamma on cytotoxicity of murine activated macrophages against murine glioma cells].
Ohyama K; Kikuchi H; Oda Y; Moritake K; Yamasaki T
No To Shinkei; 1993 Jun; 45(6):525-30. PubMed ID: 8363848
[TBL] [Abstract][Full Text] [Related]
16. Comparative oxidative microbicidal activity of human blood monocytes and alveolar macrophages and activation by recombinant gamma interferon.
Kemmerich B; Rossing TH; Pennington JE
Am Rev Respir Dis; 1987 Aug; 136(2):266-70. PubMed ID: 3113303
[TBL] [Abstract][Full Text] [Related]
17. Docosahexaenoic acid, a constituent of rodent fetal serum and fish oil diets, inhibits acquisition of macrophage tumoricidal function.
Dustin LB; Shea CM; Soberman RJ; Lu CY
J Immunol; 1990 Jun; 144(12):4888-97. PubMed ID: 2141046
[TBL] [Abstract][Full Text] [Related]
18. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes.
Fidler IJ; Fogler WE; Kleinerman ES; Saiki I
J Immunol; 1985 Dec; 135(6):4289-96. PubMed ID: 3934281
[TBL] [Abstract][Full Text] [Related]
19. The effect of recombinant interferon-gamma on human monocyte-derived macrophages.
Jungi TW; Lerch PG; Brcic M
Eur J Immunol; 1987 May; 17(5):735-8. PubMed ID: 3108018
[TBL] [Abstract][Full Text] [Related]
20. Macrophage activation to kill Leishmania major: activation of macrophages for intracellular destruction of amastigotes can be induced by both recombinant interferon-gamma and non-interferon lymphokines.
Nacy CA; Fortier AH; Meltzer MS; Buchmeier NA; Schreiber RD
J Immunol; 1985 Nov; 135(5):3505-11. PubMed ID: 3930606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
